The underlying business is doing well but the stock is way down. It has a fortified balance sheet, is growing organically`and by acquisition. They have set up a recent bank arrangement for this. It should move in line with its peers.

Unlock the latest expert's opinion. Its free

Create a FREE account to see the latest opinions & get alerts about when to buy, sell or hold stocks

Unlock opinion & get signals

(A Top Pick Nov 19/21, Down 35%) Respiration industry (repository technology and machines). Business growing well. Revenue growing with profits. Trading at 50% of multiple compared to peers. Will continue to hold shares.

(A Top Pick Sep 02/21, Down 19%) It deals in home care products, e.g. oxygen, etc. It has been growing the business by 30% over the year but the stock price is down because it is a small cap company. A different market moves them substantially higher. A recent banking deal allows for more acquisitions. It is moving from a regional player to a national one. Next year a lot of catalysts could move it higher.
It is a Canadian company operating in just the U.S. The CEO has done a good job growing the business. It screens cheaply but needs more consistent profitability.
(A Top Pick Sep 02/21, Down 30%) Health care is moving into homes so it is in a good spot. It is still making accretive acquisitions and guiding 30% higher revenue. It is in 19 states. He continues to hold the debentures.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Revenues have grown 41% since 2020 at $102M for 2021. 10% organic growth. Operational metrics are impressive that sets up the company well for future recurring revenues. Still some runway left, trading at 22x earnings. The balance sheet is healthy with net cash. Unlock Premium - Try 5i Free

Home healthcare business with chronically ill patients. Growing organically at 10% per year. They are also acquiring companies and just announced 2 acquisitions. Fantastic margin at 22% EBITDA. The stock trades at 6x next year's EBITDA compared to 10x for their peers. Buying more right now. Will go higher as it gets rerated. (Analysts’ price target is $12.23)
Chronic care, ventilators. Revenue growing at a fantastic rate, using a subscription model. Cheap compared to peers. Not a concern whether Medicare or Medicaid are cut. Perfect example of money rotation to small caps. Management owns a fairly good position. No dividend. (Analysts’ price target is $121.37)
(A Top Pick Jul 02/20, Up 72%) A US medical device company (lifts, oxyegen and other homecare products). Continues to like it, given aging demographics. The valuation is attractive. They continue to grow by acqusition, adding geographic regions and fragmented, small busineses. They have cash to buy more companies and are EBIDTA positive. Good cash flow. Expects this to get taken out one day. Price pressures are always a possibility if suppliers raise prices. Also there are reimbursement cuts in the U.S. medical system every few years, another caveat.
Showing 1 to 9 of 9 entries
  • «
  • 1
  • »

Quipt Home Medical(QIPT-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for Quipt Home Medical is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Quipt Home Medical(QIPT-X) Frequently Asked Questions

What is Quipt Home Medical stock symbol?

Quipt Home Medical is a Canadian stock, trading under the symbol QIPT-X on the TSX Venture Exchange (QIPT-CV). It is usually referred to as TSXV:QIPT or QIPT-X

Is Quipt Home Medical a buy or a sell?

In the last year, 4 stock analysts published opinions about QIPT-X. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Quipt Home Medical.

Is Quipt Home Medical a good investment or a top pick?

Quipt Home Medical was recommended as a Top Pick by on . Read the latest stock experts ratings for Quipt Home Medical.

Why is Quipt Home Medical stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Quipt Home Medical worth watching?

4 stock analysts on Stockchase covered Quipt Home Medical In the last year. It is a trending stock that is worth watching.

What is Quipt Home Medical stock price?

On 2022-12-08, Quipt Home Medical (QIPT-X) stock closed at a price of $5.96.